医学
胰岛素释放
自动化
糖尿病
重症监护医学
医疗急救
1型糖尿病
工程类
内分泌学
机械工程
作者
Michael S. Hughes,Francisco J. Pasquel,Georgia M. Davis,Rayhan A. Lal,Bruce A. Buckingham,Charlotte K. Boughton,Sue A. Brown,Lia Bally
标识
DOI:10.1089/dia.2024.0343
摘要
The introduction of automated insulin delivery (AID) systems represents a significant advancement in diabetes care, offering substantial benefits in outpatient settings. Although clinical studies suggest that these systems can also help improve glycemic control in acutely ill patients, several barriers remain for the actual implementation and use of these technologies in clinical practice. Three main contexts for inpatient use are addressed, including: (a) continuation of personal AID systems, (b) initiation of AID during hospitalization, and (c) initiation of AID systems at discharge. A research road map with immediate to long-term actions is presented. Initially, it calls for clinical studies assessing in-hospital efficacy, safety, and utility, addressing specific patient needs and health care operational impacts. Midterm, it focuses on practical integration, simplifying AID use, ensuring electronic health record compatibility, clarifying regulatory uncertainties, and supporting health care professionals and patients. Long-term goals include system optimizations and policy advocacy for in-hospital AID use.
科研通智能强力驱动
Strongly Powered by AbleSci AI